CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Restricted shares	Restricted stock units	Total stockholders’ equity attributable to T. Rowe Price Group	Total stockholders’ equity attributable to T. Rowe Price Group Restricted shares	Total stockholders’ equity attributable to T. Rowe Price Group Restricted stock units	Common stock	Common stock Restricted shares	Common stock Restricted stock units	Additional capital in excess of par value	Additional capital in excess of par value Restricted shares	Additional capital in excess of par value Restricted stock units	Retained earnings	AOCI	[1]	Non-controlling interests in consolidated entities
Beginning balances (in shares) at Dec. 31, 2022							224,310,000
Beginning balances at Dec. 31, 2022	$ 9,030.2			$ 8,839.5			$ 44.9			$ 437.9			$ 8,409.7	$ (53.0)		$ 190.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,833.3			1,788.7									1,788.7			44.6
Other comprehensive income (loss), net of tax (Loss)	5.5			5.5										5.5
Dividends declared	(1,121.9)			(1,121.9)									(1,121.9)
Common stock-based compensation plans activity:
Shares issued upon option exercises (in shares)							585,000
Shares issued upon option exercises	35.7			35.7			$ 0.1			35.6
Restricted shares issued, net of shares withheld for taxes (in shares)								57,000
Net shares issued upon vesting of restricted stock units (in shares)									1,413,000
Net shares issued upon vesting of restricted stock units			$ (53.7)			$ (53.7)			$ 0.3			$ (54.0)
Stock-based compensation expense	265.6			265.6						265.6
Restricted stock units issued as dividend equivalents	0.0									0.4			(0.4)
Common shares repurchased (in shares)							(2,427,000)
Common shares repurchased	(254.3)			(254.3)			$ (0.5)			(253.8)
Net distributions to non-controlling interests in consolidated entities	(43.3)															(43.3)
Ending balances (in shares) at Dec. 31, 2023							223,938,000
Ending balances at Dec. 31, 2023	9,697.1			9,505.1			$ 44.8			431.7			9,076.1	(47.5)		192.0
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2022	656.7
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income	47.0
Other comprehensive income, net of tax	12.7
Net subscriptions into T. Rowe Price investment products	356.9
Net deconsolidations of T. Rowe Price investment products	(479.2)
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2023	594.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,105.5			2,100.1									2,100.1			5.4
Other comprehensive income (loss), net of tax (Loss)	(4.2)			(4.2)										(4.2)
Dividends declared	(1,135.2)			(1,135.2)									(1,135.2)
Common stock-based compensation plans activity:
Shares issued upon option exercises (in shares)							577,000
Shares issued upon option exercises	36.4			36.4			$ 0.1			36.3
Restricted shares issued, net of shares withheld for taxes (in shares)								7,000
Restricted shares issued, net of shares withheld for taxes		$ (0.3)			$ (0.3)						$ (0.3)
Net shares issued upon vesting of restricted stock units (in shares)									1,415,000
Net shares issued upon vesting of restricted stock units			(69.3)			(69.3)			$ 0.3			(69.6)
Stock-based compensation expense	247.3			247.3						247.3
Restricted stock units issued as dividend equivalents	0.0									0.4			(0.4)
Common shares repurchased (in shares)							(2,971,000)
Common shares repurchased	(334.5)			(334.5)			$ (0.6)			(333.9)
Net distributions to non-controlling interests in consolidated entities	(36.7)															(36.7)
Ending balances (in shares) at Dec. 31, 2024							222,966,000
Ending balances at Dec. 31, 2024	10,506.1			10,345.4			$ 44.6			311.9			10,040.6	(51.7)		160.7
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income	35.7
Other comprehensive income, net of tax	(5.0)
Net subscriptions into T. Rowe Price investment products	592.0
Net deconsolidations of T. Rowe Price investment products	(272.8)
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2024	944.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,117.9			2,087.1									2,087.1			30.8
Other comprehensive income (loss), net of tax (Loss)	1.2			1.2										$ 1.2
Dividends declared	$ (1,143.4)			(1,143.4)									(1,143.4)
Common stock-based compensation plans activity:
Shares issued upon option exercises (in shares)	642,149						495,000
Shares issued upon option exercises	$ 31.6			31.6			$ 0.1			31.5
Restricted shares issued, net of shares withheld for taxes (in shares)								0
Restricted shares issued, net of shares withheld for taxes		$ (0.2)			$ (0.2)						$ (0.2)
Net shares issued upon vesting of restricted stock units (in shares)									1,279,000
Net shares issued upon vesting of restricted stock units			$ (53.9)			$ (53.9)			$ 0.3			$ (54.2)
Stock-based compensation expense	216.9			216.9						216.9
Restricted stock units issued as dividend equivalents										0.5			(0.5)
Common shares repurchased (in shares)							(6,175,000)
Common shares repurchased	(624.6)			(624.6)			$ (1.2)			$ (506.4)			$ (117.0)
Net distributions to non-controlling interests in consolidated entities	(34.4)															$ (34.4)
Ending balances (in shares) at Dec. 31, 2025							218,565,000
Ending balances at Dec. 31, 2025	11,017.2			$ 10,860.1
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income	121.2
Other comprehensive income, net of tax	9.8
Net subscriptions into T. Rowe Price investment products	556.0
Net deconsolidations of T. Rowe Price investment products	(595.0)
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2025	$ 1,036.0

[1] Accumulated other comprehensive income